Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework Agreement for South of England Branded - Tranche B and Annual

NHS England

This public procurement record has 1 release in its history.

Award

12 Aug 2022 at 11:21

Award Notice
Summary of the contracting process

The NHS England has awarded a contract for the NHS Framework Agreement for South of England Branded Medicines. The procurement process was initiated through a tender and resulted in a contract value of £338,655,597 GBP. The procurement method used was an open procedure above the threshold. The contract period spans from 1st September 2022 to 31st August 2024, with possible extensions. The tender period ended on 12th April 2022, and the contract award was finalised on 15th July 2022.

This tender presents significant opportunities for pharmaceutical companies specialising in branded medicines. Businesses in the pharmaceutical products industry, particularly those operating in the South of England region, should consider engaging with NHS England as potential suppliers. Small and medium-sized enterprises (SMEs) interested in pharmaceutical procurement for the public sector could find this opportunity particularly beneficial due to the stated suitability for SMEs by the contracting authority.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement for South of England Branded - Tranche B and Annual

Notice Description

NHS South of England Branded Medicines - Tranche B Offer reference number: CM/PHR/20/5611 CM/PHR/20/5611/01 - NHS Framework for SOUTH of England Branded Medicines - Tranche B. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5611/02 - NHS Framework for the SOUTH of England Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-4c9013e7-bbb5-4254-b8ad-705ccb4e5887
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/45030f89-3656-41f2-949b-7584f9cdd0fc
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£338,655,597 £100M-£1B
Lots Value
Not specified
Awards Value
£338,655,597 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
12 Aug 20224 years ago
Submission Deadline
12 Apr 2022Expired
Future Notice Date
Not specified
Award Date
15 Jul 20224 years ago
Contract Period
1 Sep 2022 - 31 Aug 2024 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
29
Supplier Names

Accord-UK Ltd

Almirall

AstraZeneca

Aventis Pharma ltd t/a Sanofi

Bayer Plc

Biogen

CST Pharma Limited

Celltrion Healthcare United Kingdom Limited

Eli Lilly & Company Ltd

Gedeon Richter UK Ltd

GlaxoSmithKline UK Limited

Ipsen

Janssen-Cilag Ltd

Merck Serono Limited

Merck Sharpe & Dohme (UK) Limited

Mylan

Novo Nordisk

Organon Pharmaceuticals UK Ltd

Pfizer Ltd

Roche Products Ltd

Sandoz Ltd

Sobi (Swedish Orphan Biovitrum Ltd)

Takeda UK Ltd

Teva UK Limited

Thornton and Ross Ltd

Typharm Ltd

UCB Pharma Ltd (primary)

UL Global Pharma

Zentiva Pharma UK Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...